Post by christopher on Sept 20, 2016 11:34:32 GMT -5
While reading the first main paragraph where the list of companies and their ratings are listed, we are shown again the incompetency regarding anything to do with Zacks. Story below was written on Septmeber 20, 2016
Zacks shows to have an upgrade on their rating of AMCC from "sell" to "hold" on July 28.
What about their recent downgrade to "sell" occurring well after July 28.
Luckily, someone new is now supporting AMCC "Susquehanna" at Neutral.
BUT,
Where are the BUY ratings? wouldn't NOW be the time to be buying AMCC?? before the GROWTH occurs!!!!!
Post by christopher on Sept 20, 2016 12:37:00 GMT -5
phobos,
I will continue my rant here and will also add in time, to what you have stated regarding "Roth"
From Q1 CC:
" revenues will range between $41M to 42M. We have excellent backlog coverage. Our overall revenues are essentially flat due to the headwinds associated with the older products. We expect these headwinds to abate toward the end of our fiscal year, thereby making a new product revenue growth more apparent. To provide you with further context, in the first quarter of fiscal 2017, we achieved the highest number and dollar amount of design wins that we've seen over the past two years. In fact we closed five times the total dollar amount of design wins in the first quarter of fiscal 2017 as compared with the first quarter of fiscal 2016."
Then where the HELL does ALL of this revenue come into play??? are we being lied to?
phobos, please send your questions to board@apm.com I have sent some questions and complaints. the more that send the better the response.
below is a response from Gopi during the Q1 CC:
"The new product growth is happening. You see it. in fact, I've never seen a bigger, I'll call it a more deliberate and clear ramp of a new product set that I see this year. Obviously, right, with product transitions and changes, with some of the older products, it's masked and I think masking effect will start to go away in 2017."
Last Edit: Sept 20, 2016 12:40:56 GMT -5 by christopher
"...masking effect will start to go away in 2017."
OK. Roth has it going away in 2017: earnings go from $41M in the third quarter to $42M in the fourth. I really don't know how management could be vaguer. Is this a ramp or is this a RAMP? With all the qualifiers and the mincing, I really don't know. Roth doesn't seem convinced either. ?!?!
I think one of the problems with AMCC is that potential suitors who want the compute business may not want the connectivity business, and vice versa. If someone could buy the company and then sell the part they don't want... but there would have to be that secondary buyer.
I think both MCSI and CAVM were both too expensive. Even if AMCC sells at a moderate price, we should do OK.
Zepf has to be leaning on management to broker a sale (he has to).
Post by christopher on Sept 21, 2016 13:12:04 GMT -5
phobos,
I just noticed your response from above: "Roth doesn't seem convinced either"
Odd how on top of it all, Roth just put out a $8 price target on AMCC
I believe Zepf is the KEY individual in all of this. mucho dinero on the line
One other item I would like to add here:
over the past year there have been multiple, a high multiple of purchasers of shares of AMCC.
and there have only been maybe TWO that have sold. All but the two continue to HOLD
I have a feeling that everyone, except the one or two have a definite SALE on their minds and not a sale of shares at let's say $8. more like a double digit sale of the company. one can hope.
Last Edit: Sept 21, 2016 13:37:48 GMT -5 by christopher
if a conversation regarding "sale" were taking place, then it obviously would help with a growing number of above range targets being placed.
I will say again, there have been a large number of smaller shares being purchased and then being held. Volume for the past few days has been on the low side. Nobody seems to be selling.
Last Edit: Sept 22, 2016 12:52:42 GMT -5 by christopher